Bart Westendorp

1.6k total citations
41 papers, 869 citations indexed

About

Bart Westendorp is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bart Westendorp has authored 41 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Oncology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bart Westendorp's work include Cancer-related Molecular Pathways (11 papers), DNA Repair Mechanisms (7 papers) and Ubiquitin and proteasome pathways (7 papers). Bart Westendorp is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), DNA Repair Mechanisms (7 papers) and Ubiquitin and proteasome pathways (7 papers). Bart Westendorp collaborates with scholars based in Netherlands, United States and Pakistan. Bart Westendorp's co-authors include Alain de Bruin, Shusil K. Pandit, Peter C.J. Tooten, Michal Mokrý, M.J.M. Toussaint, Frank C. P. Holstege, Marian J.A. Groot Koerkamp, Edwin Cuppen, Walbert J. Bakker and Sathidpak Nantasanti and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Journal of the American College of Cardiology.

In The Last Decade

Bart Westendorp

37 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Westendorp Netherlands 16 604 270 167 152 79 41 869
Yuping Chen China 15 681 1.1× 263 1.0× 139 0.8× 170 1.1× 111 1.4× 41 1.2k
Jinmei Yu China 15 616 1.0× 234 0.9× 211 1.3× 209 1.4× 55 0.7× 28 1.1k
Carolyn Kemp United States 9 381 0.6× 123 0.5× 112 0.7× 186 1.2× 57 0.7× 11 747
Wenfang Tian China 17 588 1.0× 247 0.9× 152 0.9× 87 0.6× 94 1.2× 34 1.1k
Keith Blomenkamp United States 21 505 0.8× 296 1.1× 335 2.0× 297 2.0× 136 1.7× 36 1.2k
Saioa Goñi Spain 16 504 0.8× 156 0.6× 171 1.0× 98 0.6× 116 1.5× 28 900
Mary C. Stevenson United States 12 395 0.7× 289 1.1× 97 0.6× 58 0.4× 114 1.4× 14 869
Daniel Chang United States 13 504 0.8× 110 0.4× 322 1.9× 62 0.4× 77 1.0× 16 907
E. Spitzer Germany 15 499 0.8× 412 1.5× 109 0.7× 73 0.5× 77 1.0× 26 910

Countries citing papers authored by Bart Westendorp

Since Specialization
Citations

This map shows the geographic impact of Bart Westendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Westendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Westendorp more than expected).

Fields of papers citing papers by Bart Westendorp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Westendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Westendorp. The network helps show where Bart Westendorp may publish in the future.

Co-authorship network of co-authors of Bart Westendorp

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Westendorp. A scholar is included among the top collaborators of Bart Westendorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Westendorp. Bart Westendorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stapels, Daphne A. C., Bart Westendorp, Richard Wubbolts, et al.. (2024). MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase C. Journal of Cell Science. 137(5). 9 indexed citations
2.
Lyoo, Heyrhyoung, Bart Westendorp, Maarten Altelaar, et al.. (2024). Assessment of Kinome-Wide Activity Remodeling upon Picornavirus Infection. Molecular & Cellular Proteomics. 23(5). 100757–100757. 2 indexed citations
3.
Chatterjee, Maitrayee, Anna Z. Mykytyn, Chunyan Wang, et al.. (2023). Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface. PLoS Pathogens. 19(8). e1011571–e1011571. 19 indexed citations
4.
5.
Roukens, M. Guy, Daniëlle Seinstra, Luca Braccioli, et al.. (2021). Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferation. Oncogene. 40(45). 6343–6353. 14 indexed citations
6.
Riemers, Frank M., et al.. (2020). Excessive E2F Transcription in Single Cancer Cells Precludes Transient Cell-Cycle Exit after DNA Damage. Cell Reports. 33(9). 108449–108449. 20 indexed citations
7.
Sladky, Valentina C., Tamás Szabó, Laura Bongiovanni, et al.. (2020). PIDDosome‐induced p53‐dependent ploidy restriction facilitates hepatocarcinogenesis. EMBO Reports. 21(12). e50893–e50893. 28 indexed citations
8.
Kruitwagen, Hedwig S., Bart Westendorp, Cornelia S. Viebahn, et al.. (2017). DYRK1A Is a Regulator of S-Phase Entry in Hepatic Progenitor Cells. Stem Cells and Development. 27(2). 133–146. 5 indexed citations
9.
Weijts, Bart, Bart Westendorp, Rachel Thomas, et al.. (2017). Atypical E2Fs inhibit tumor angiogenesis. Oncogene. 37(2). 271–276. 18 indexed citations
10.
Westendorp, Bart, Raoul Kuiper, Peter C.J. Tooten, et al.. (2016). Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer. Oncogene. 36(6). 829–839. 52 indexed citations
11.
Bakker, Walbert J., Bart Weijts, Bart Westendorp, & Alain de Bruin. (2013). HIF proteins connect the RB-E2F factors to angiogenesis. Transcription. 4(2). 62–66. 17 indexed citations
12.
Pandit, Shusil K., Bart Westendorp, Sathidpak Nantasanti, et al.. (2012). E2F8 is essential for polyploidization in mammalian cells. Nature Cell Biology. 14(11). 1181–1191. 124 indexed citations
13.
Westendorp, Bart, Michal Mokrý, Marian J.A. Groot Koerkamp, et al.. (2011). E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. Nucleic Acids Research. 40(8). 3511–3523. 96 indexed citations
14.
Westendorp, Bart, Regien G. Schoemaker, Hendrik Buikema, et al.. (2005). Beneficial Effects of Add-On Hydrochlorothiazide in Rats with Myocardial Infarction Optimally Treated with Quinapril. European Journal of Heart Failure. 7(7). 1085–1094. 6 indexed citations
15.
Westendorp, Bart, Regien G. Schoemaker, Hendrik Buikema, et al.. (2005). Progressive Left Ventricular Hypertrophy After Withdrawal of Long-Term ACE Inhibition Following Experimental Myocardial Infarction. European Journal of Heart Failure. 8(2). 122–130. 8 indexed citations
16.
Westendorp, Bart, Regien G. Schoemaker, Wiek H. van Gilst, Dirk J. van Veldhuisen, & Hendrik Buikema. (2005). Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: Differential effects on lisinopril and zofenopril. European Journal of Pharmacology. 527(1-3). 141–149. 9 indexed citations
17.
Westendorp, Bart, Regien G. Schoemaker, Wiek H. van Gilst, & Hendrik Buikema. (2005). Improvement of EDHF by Chronic ACE Inhibition Declines Rapidly After Withdrawal in Rats With Myocardial Infarction. Journal of Cardiovascular Pharmacology. 46(6). 766–772. 6 indexed citations
18.
Westendorp, Bart, Rik C. Schoemaker, Hendrik Buikema, & Wiek H. van Gilst. (2004). Withdrawing chronic quinapril treatment causes rebound volume overload and endothelial dysfunction in rats with myocardial infarction. Data Archiving and Networked Services (DANS).
19.
Westendorp, Bart, et al.. (2004). Hydrochlorothiazide increases tissue concentrations of the ACE inhibitor zofenoprilat in rats with myocardial infarction. Data Archiving and Networked Services (DANS).
20.
Westendorp, Bart, Regien G. Schoemaker, Hendrik Buikema, Wiek H. van Gilst, & Dirk J. van Veldhuisen. (2004). 1041-100 Hydrochlorothiazide further improves survival during angiotensin-converting enzyme inhibitor therapy after experimental myocardial infarction. Journal of the American College of Cardiology. 43(5). A257–A257.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuping Chen Breakdown of academic impact, for papers by Jinmei Yu Breakdown of academic impact, for papers by Carolyn Kemp Breakdown of academic impact, for papers by Wenfang Tian Breakdown of academic impact, for papers by Keith Blomenkamp Breakdown of academic impact, for papers by Saioa Goñi Breakdown of academic impact, for papers by Mary C. Stevenson Breakdown of academic impact, for papers by Daniel Chang Breakdown of academic impact, for papers by E. Spitzer
Rankless by CCL
2026